Top-notch scientific excellence
The BioRegion of Catalonia hosts 89 research institutions and infrastructures which are developing activities in life sciences and healthcare:
Catalonia is currently one of the leading research hubs in Europe
Some indicators even outperform those of other European economies used for comparison
EU contribution in M€ to different countries
attracted
Source: Cordis 2018
Moving cutting-edge science towards patients
Improving human health through innovation is a message that all the different interests and ideologies can share, and it is one that will help build the alliances of public and private stakeholders needed to drive change.
Jordi Naval, CEO of Biocat
The BioRegion is steadily progressing from a cutting-edge science system to a network of startups bringing therapies to clinical development. BioRegion companies have 3 molecules in Phase III. In just 2 years, the number of molecules at Phase II has increased, mainly in Oncology and Skin/Subcutaneous tissue. If we focus on medical devices, diagnostics and other health technologies, the market is also progressing at the same rate, although the extent is slightly more difficult to quantify.
Biotechnology pipeline (therapeutics)
Sources: Biocat’s Directory and clinicaltrials.gov
For 30 years, Catalonia’s successive governments have been investing in higher education and scientific excellence. The real drivers of this success are Catalonia’s universities, research centers and large R&D infrastructures, along with a set of policies focused on excellence providing the institutions with the flexibility and autonomy they need to perform their activities.
Biocat Report 2017